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Abstract
Background: EMO syndrome, defined as a triad including exophthalmus, pretibial myxedema and
osteoarthropathia, is a rare condition in patients suffering from hyperthyreosis.
Case presentation: We here describe an interesting case of EMO syndrome associated with
unilateral fibromatosis of the hand and an initial stage of generalized myxedema of the skin. To our
knowledge a similar case has not yet been described in literature though reports about associated
fibromatosis, e.g. located retroperitoneally, already exist. Familiar explanations include its initiation
by autoimmune processes or aberrant T-cell cytokine stimulation leading to an overwhelming
production of glycosaminoglycans.
Conclusion: Interpreting our case in context with previous reports we conclude that associated
fibromatosis induced by autoimmune processes may affect a variety of different localizations and
therefore requires careful monitoring. A therapeutical attempt by using UVA1 irridation for
pretibial myxedema remained without a satisfying regression.
Background
EMO syndrome is a rare condition seen in patients suffer-
ing from hyperthyreosis. It is defined as a triad of exoph-
thalmus, pretibial myxedema and osteoarthropathia
occurring in less than 1% of patients suffering from
Graves' disease [1]. We here describe an unusual case of
EMO syndrome associated with unilateral fibromatosis
and an initial stage of generalized myxedema of the skin.
Case presentation
In October 2003, a 64-year-old male Caucasian patient
was admitted with aggravating pretibial myxedema. Five
years ago, he was diagnosed with hyperthyreosis caused
by Plummer's disease. Laboratory findings revealed a
repressed TSH of 0.01 mU/L (0.4–4.0 mU/L). The patient
was treated with radioiodine therapy. Today he suffers
from hypothyreosis and a daily substitution of 100 µg L-
Thyroxin is performed. Within the months following the
radioiodine therapy, an erythema progressing into a man-
ifest pretibial myxedema developed, followed by exoph-
thalmus and fibromatosis of the right hand within the
next three years. Surgical orbita decompression due to
massive exophthalmus was performed, followed by a sub-
sequent correction of the ocular muscles. Additionally,
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the fibromatosis of the right hand was excised. Retrospec-
tive histological findings revealed a regressive sclerotic
fibrosis of firm kollagenous fibers embedded in soft and
fat tissue were consistent with a generalized fibrosing
process as known in myxedema. Within the last months,
decent mucous plaques of the upper limps decreased. The
patient now reported progressing congestion of lymph
and decreasing flexibility of the lower legs caused by the
pretibial myxedema. Clinical examination confirmed
massive pretibial myxedema, lymphatic congestion of the
lower legs, generalized myxedema accentuating the upper
limps, a residual postsurgical nodular tumor of the ulnar
aspect of the right hand, exophthalmus, and severe hyper-
trophic osteopathy of the distal phalanges with clubbed
fingers and hippocratic nails (Fig. 1). A Complete check-
up including autoantibodies remained unremarkable.
Under substitution of 100 µg L-Throxin daily we found
the following thyroidal values: T3 0.94 ng/ml (0.59–
1.74), T4 10.17 µg/dl (4.50–12.00), TSH 0.47 µIE/ml
(0.38–4.70), fT3 2.64 pg/ml (1.45–3.48), fT4 1.44 ng/dl
(0.71–1.85). There were no hints for additional fibroma-
tosis. The classical combination of exophthalmus, pretib-
Pretherapeutic clinical appearance of a 64-year-old patient consistent with the diagnosis of EMO syndrome, exophthalmus (a),  combined lymphatic congestion and pretibial myxedema (b) and palmoulnar fibromatosis (intrasurgical, c) Figure 1
Pretherapeutic clinical appearance of a 64-year-old patient consistent with the diagnosis of EMO syndrome, exophthalmus (a), 
combined lymphatic congestion and pretibial myxedema (b) and palmoulnar fibromatosis (intrasurgical, c).Publish with BioMed Central    and   every 
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ial myxedema and acropachy led to the diagnosis of EMO
syndrome associated with fibromatosis of the right hand
and a beginning generalized myxedema of the skin.
Conclusions
Grave's disease is known to eventually develop after radi-
oiodine therapy [2] and this may be followed by a EMO
syndrome. To our knowledge this is the first report about
a EMO syndrome combined with coexistent palmoulnar
fibromatosis. The patient was treated with lymphdrainage
and physiological compressive therapy. As Farr et al. [3]
reported the successful use of PUVA in a case of sclero-
myxedema, we initiated a therapeutic attempt with con-
ventional UVA1 irradiation five times a week for one week
followed by three times per week for three consecutive
weeks (20 J/cm2 single dose, 280 J/cm2 cumulative dose).
While the congestion of lymph clearly improved, pretibial
myxedema remained without any signs of regression.
A massive recurrence after excision of thyroid dermopa-
thy, as described in literature, could not be observed in
our patient during a follow-up of 2.5 years.
Generalized fibrosing processes are thought to be based
on an accumulation of glycosaminogylcans. Common
explanations comprise its initiation by autoimmune proc-
esses, e.g. thyreotropin receptors on fibroblasts, or aber-
rant T-cell cytokine stimulation, leading to overwhelming
glycosaminoglycan production [4] Fibrosing processes
such as retroperitoneal or sellar associated with EMO syn-
drome or multifocal fibrosclerosis, respectively, have been
previously reported [5,6]. Nevertheless, coexistent palmar
fibromatosis so far has not been described.
Therefore, we conclude that concomitant fibromatosis
might appear in various localizations requiring elaborated
diagnostic procedures and monitoring in all patients
affected. We started low-dose UVA1 irradiation of the
pretibial myxedema known to be able to degrade patho-
logic collagenous architecture by inducing dermal matrix-
metalloproteinases as well as by decreasing abnormal
cytokine liberation following T-cell apoptosis [7]. Never-
theless, our patient discontinued UVA1 phototherapy due
to non response after a cumulative dosage of 280 J/cm2
UVA1 (seven treatment sessions). However, we suggest
that phototherapy might also be considered as an adjunct
therapeutic alternative in persistent EMO syndrome.
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